A Double-blind, Fixed-dose Study of Escitalopram in Adult Patients With Major Depressive Disorder
A Double-blind, Fixed-dose Study of Escitalopram in Adult Patients With Major Depressive Disorder
This is a short-term study to evaluate the efficacy, safety, and tolerability of escitalopram in adult patients (18 to 65 years of age) with moderate to severe depression. Patients completing the study may be eligible to enter a long-term open-label extension study with escitalopram.
Inclusion Criteria:
Exclusion Criteria:
Overland, Kansas 66221, United States